IRONWOOD PHARMACEUTICALS INC (IRWD) › Cash & EquivalentsIRONWOOD PHARMACEUTICALS INC (IRWD) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2008: $66.33M2009: $122.31M2010: $44.32M2011: $87.28M2012: $136.70M2013: $75.49M2014: $74.30M2015: $261.29M2016: $54.00M2017: $125.74M2018: $173.17M2019: $177.02M2020: $362.56M2021: $620.13M2022: $656.20M2023: $92.15M2024: $88.56M2025: $215.46M$215.46M2008Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$215.46M+143.3%2024$88.56M-3.9%2023$92.15M-86.0%2022$656.20M+5.8%2021$620.13M+71.0%2020$362.56M+104.8%2019$177.02M+2.2%2018$173.17M+37.7%2017$125.74M+132.8%2016$54.00M-79.3%2015$261.29M+251.7%2014$74.30M-1.6%2013$75.49M-44.8%2012$136.70M+56.6%2011$87.28M+96.9%2010$44.32M-63.8%2009$122.31M+84.4%2008$66.33M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share